Home Subjects Market

Market

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

Since the MAH pilot launch, the company has undertaken eight development programs New Delhi, December 04, 2017: STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies...

Shalby Limited: PublicOffer opens on Tuesday, December 5, 2017, closes on Thursday, December 7,...

Mumbai, November 29, 2017: Shalby Limited (the “Company”) proposes to open, an initial public offering of equity shares of face value of Rs. 10 each (“Equity Shares”) for cash at aPrice including ashare premium (the “Offer”) on Tuesday, December...

India can play role in global marketing of herbal products: Naik

New Delhi, November 24, 2017: India can play a leading role in the global market of herbal product and drugs, Minister of State (independent charge) for AYUSH Sripad Yesso Naik said on Wednesday. Addressing the inaugural session of the review meeting...

New treatments to solve global antibiotic crisis have potential to reach the market as...

Helperby Therapeutics has developed the first sustainable solution to combat all three deadly critical priority pathogens named by World Health Organisation New ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance London, November 20, 2017: Helperby Therapeutics (Helperby), a pioneering...

RG Stone Hospitals plans big expansion

NEW DELHI, May 01, 2014: RG Stone Urology and Laparoscopy Hospitals plans to expand to 25 centres in two-and-a-half years, Hanish Bansal, Executive Director, said. The Delhi-based hospital chain, which achieved a turnover of Rs.110 crore last year and...

Broad-Based Business Momentum Helps Biocon Deliver 16% Revenue Growth in FY14

Bangalore, April 25, 2014 - Commenting on the quarterly performance and highlights, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, “Biocon ended fiscal 2014 on a strong note. We delivered 16% revenue growth along with a healthy EBITDA...

Lupin recalls two lots of ‘Suprax’ in U.S. market

New Delhi, April 18, 2014 - Drug major Lupin is voluntarily recalling 9,210 bottles of its antibiotic drug Suprax, used to treat bacterial infections, in the U.S. market, according to the U.S. Food and Drug Administration (USFDA). As per the...

Sun blazes with $4-billion Ranbaxy buy

Mumbai, April 08,2014 - Drugmaker Sun Pharma sent ripples across the pharmaceutical industry on Monday morning as it agreed to buy out the troubled Ranbaxy in a $4-billion (including $800-million debt), all-stock deal, in the process creating India’s largest...

Big Pharma still betting on “messed up” Indian drugs market

Mumbai March 13,2014: Global drugmakers have had a nauseous time in India`s USD 14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 percent of people...

Will the Ranbaxy imbroglio hurt Brand India?

New Delhi March 10, 2014 : Indian companies export about $14 billion worth pharmaceuticals every year and a majority of this are US-bound. In recent months, however, India's drug-makers have been rattled by a rash of US regulatory...